Literature DB >> 8135750

Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism.

J W Miller1, M R Nadeau, J Smith, D Smith, J Selhub.   

Abstract

In a recent hypothesis [Selhub and Miller (1992) Am. J. Clin. Nutr. 55, 131-138], we proposed that homocysteinaemia arises from an interruption in S-adenosylmethionine's (AdoMet) coordinate regulation of homocysteine metabolism. The present study was undertaken to test a prediction of this hypothesis, that homocysteinaemia due to folate deficiency results from impaired homocysteine remethylation due to the deficiency and impaired synthesis of AdoMet, with the consequent inability of this metabolite to function as an activator of homocysteine catabolism through cystathionine synthesis. Rats were made folate-deficient by feeding them with a folate-free amino-acid-defined diet supplemented with succinylsulphathiazole. After 4 weeks, the deficient rats exhibited a 9.8-fold higher mean plasma homocysteine concentration and a 3.2-fold lower mean hepatic AdoMet concentration compared with folate-replete controls. Subsequent supplementation for 3 weeks of the folate-deficient rats with increasing levels of folate in the diet resulted in graded decreases in plasma homocysteine levels, accompanied by graded increases in hepatic AdoMet levels. Thus plasma homocysteine and hepatic AdoMet concentrations were inversely correlated as folate status was modified. In a second experiment, the elevation of plasma homocysteine in the deficient rats was found to be reversible within 3 days by intraperitoneal injections of ethionine. This effect of ethionine is thought to be exerted through S-adenosylethionine, which is formed in the liver of these rats. Like AdoMet, S-adenosylethionine is an activator of cystathionine beta-synthase and will effectively promote the catabolism of homocysteine through cystathionine synthesis. In crude liver homogenates of the rats treated with ethionine, cystathionine beta-synthase activity was 3-fold higher than that measured in homogenates from vehicle-treated controls.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135750      PMCID: PMC1137956          DOI: 10.1042/bj2980415

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

Review 1.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

Authors:  P M Ueland; H Refsum
Journal:  J Lab Clin Med       Date:  1989-11

2.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

Authors:  M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine.

Authors:  J Selhub; J W Miller
Journal:  Am J Clin Nutr       Date:  1992-01       Impact factor: 7.045

5.  Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors.

Authors:  L Brattström; A Lindgren; B Israelsson; M R Malinow; B Norrving; B Upson; A Hamfelt
Journal:  Eur J Clin Invest       Date:  1992-03       Impact factor: 4.686

6.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.

Authors:  A Araki; Y Sako
Journal:  J Chromatogr       Date:  1987-11-27

Review 7.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.

Authors:  L Brattström; B Israelsson; B Norrving; D Bergqvist; J Thörne; B Hultberg; A Hamfelt
Journal:  Atherosclerosis       Date:  1990-02       Impact factor: 5.162

8.  Plasma homocyst(e)ine levels in men with premature coronary artery disease.

Authors:  J J Genest; J R McNamara; D N Salem; P W Wilson; E J Schaefer; M R Malinow
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

9.  Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium.

Authors:  D A Jencks; R G Mathews
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

10.  Repletion of folate-depleted rats with an amino acid-based diet supplemented with folic acid.

Authors:  A J Clifford; D S Wilson; N D Bills
Journal:  J Nutr       Date:  1989-12       Impact factor: 4.798

View more
  39 in total

1.  One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore.

Authors:  Maki Inoue-Choi; Heather H Nelson; Kim Robien; Erland Arning; Teodoro Bottiglieri; Woon-Puay Koh; Jian-Min Yuan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad Nasir Uddin; Tariqul Islam; Vesna Ilievski; Joseph H Graziano; Mary V Gamble
Journal:  J Nutr       Date:  2015-08-26       Impact factor: 4.798

3.  Palm tocotrienol-rich fraction inhibits methionine-induced cystathionine β-synthase in rat liver.

Authors:  Yusof Kamisah; Ku-Zaifah Norsidah; Ayob Azizi; Othman Faizah; Mohd Rizal Nonan; Ahmad Yusof Asmadi
Journal:  J Physiol Biochem       Date:  2015-09-25       Impact factor: 4.158

4.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

5.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.

Authors:  S C Lu; L Alvarez; Z Z Huang; L Chen; W An; F J Corrales; M A Avila; G Kanel; J M Mato
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

6.  Folate-dependent methylation of septins governs ciliogenesis during neural tube closure.

Authors:  Manami Toriyama; Michinori Toriyama; John B Wallingford; Richard H Finnell
Journal:  FASEB J       Date:  2017-04-21       Impact factor: 5.191

7.  Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig.

Authors:  Charles H Halsted; Jesus A Villanueva; Angela M Devlin; Onni Niemelä; Seppo Parkkila; Timothy A Garrow; Lynn M Wallock; Mark K Shigenaga; Stepan Melnyk; S Jill James
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

8.  Structure of Staphylococcus aureus 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.

Authors:  Karen K W Siu; Jeffrey E Lee; G David Smith; Cathy Horvatin-Mrakovcic; P Lynne Howell
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-04-30

9.  Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE.

Authors:  Shyue-fang Battaglia-Hsu; Nassila Akchiche; Nicole Noel; Jean-Marc Alberto; Elise Jeannesson; Carlos Enrique Orozco-Barrios; Daniel Martinez-Fong; Jean-Luc Daval; Jean-Louis Guéant
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-03       Impact factor: 11.205

10.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.